<?xml version="1.0"?>
<case>
<name>CSL Limited v GlaxoSmithKline Australia Pty Ltd [2006] FCA 1301 (3 October 2006)</name>
<AustLII>http://www.austlii.edu.au/au/cases/cth/FCA/2006/1301.html</AustLII>
<citphrases>
<citphrase id="cp0.0" type=cited from="[2006] HCA 46">australian broadcasting corporation v o'neill  defamation</citphrase>
<citphrase id="cp0.1" type=cited from="[2006] HCA 46">injunctions</citphrase>
<citphrase id="cp0.2" type=cited from="[2006] HCA 46">interlocutory injunctions</citphrase>
<citphrase id="cp0.3" type=cited from="[2006] HCA 46">interlocutory injunction to restrain publication</citphrase>
<citphrase id="cp0.4" type=cited from="[2006] HCA 46">appellant restrained from broadcasting documentary film making allegations including that respondent suspected of having committed notorious unsolved crime</citphrase>
<citphrase id="cp0.5" type=cited from="[2006] HCA 46">principles on which interlocutory injunction to restrain publication granted</citphrase>
<citphrase id="cp0.6" type=cited from="[2006] HCA 46">relevance of "flexible" or "rigid" approaches to granting interlocutory injunctions</citphrase>
<citphrase id="cp0.7" type=cited from="[2006] HCA 46">significance of value of free speech</citphrase>
<citphrase id="cp0.8" type=cited from="[2006] HCA 46">significance of avoiding "trial by media"</citphrase>
<citphrase id="cp0.9" type=cited from="[2006] HCA 46">whether relevant that only nominal damages likely to be awarded</citphrase>
<citphrase id="cp0.10" type=cited from="[2006] HCA 46">significance of status of respondent as convicted life prisoner.  injunctions</citphrase>
<citphrase id="cp0.11" type=cited from="[2006] HCA 46">interlocutory injunctions</citphrase>
<citphrase id="cp0.12" type=cited from="[2006] HCA 46">defamation</citphrase>
<citphrase id="cp0.13" type=cited from="[2006] HCA 46">whether general principles governing grant of interlocutory injunctions to restrain wrongs apply to interlocutory applications to restrain publication of allegedly defamatory matter</citphrase>
<citphrase id="cp0.14" type=cited from="[2006] HCA 46">relationship between beecham group ltd v bristol laboratories pty ltd [1968] hca 1 ; (1968) 118 clr 618 and american cyanamid co v ethicon ltd [1975] ukhl 1 ; [1975] ac 396</citphrase>
<citphrase id="cp0.15" type=cited from="[2006] HCA 46">whether respondent had made out an entitlement to an interlocutory injunction within the principles established by beecham</citphrase>
<citphrase id="cp0.16" type=cited from="[2006] HCA 46">whether full court and primary judge shown to have erred in granting of interlocutory injunction.  defamation</citphrase>
<citphrase id="cp0.17" type=cited from="[2006] HCA 46">injunctions</citphrase>
<citphrase id="cp0.18" type=cited from="[2006] HCA 46">jurisdiction to grant interlocutory injunction to restrain publication of allegedly defamatory matter</citphrase>
<citphrase id="cp0.19" type=cited from="[2006] HCA 46">nature of equitable jurisdiction to grant injunctions to restrain publication</citphrase>
<citphrase id="cp0.20" type=cited from="[2006] HCA 46">effect of common law procedure act 1854 (uk)</citphrase>
<citphrase id="cp0.21" type=cited from="[2006] HCA 46">effect of judicature act 1873 (uk).  appeal</citphrase>
<citphrase id="cp0.22" type=cited from="[2006] HCA 46">interlocutory injunction in defamation proceedings</citphrase>
<citphrase id="cp0.23" type=cited from="[2006] HCA 46">necessity of demonstrating error in order to justify intervention by high court</citphrase>
<citphrase id="cp0.24" type=cited from="[2006] HCA 46">whether error shown in approach and conclusion of full court and primary judge.  defamation</citphrase>
<citphrase id="cp0.25" type=cited from="[2006] HCA 46">defences</citphrase>
<citphrase id="cp0.26" type=cited from="[2006] HCA 46">justification</citphrase>
<citphrase id="cp0.27" type=cited from="[2006] HCA 46">whether avoiding "trial by media" relevant to determination of "public benefit" required by defamation act 1957 (tas) s 15.</citphrase>
<citphrase id="cp1.0" type=cited from="[2005] FCA 1218">patents</citphrase>
<citphrase id="cp1.1" type=cited from="[2005] FCA 1218">interlocutory injunctions</citphrase>
<citphrase id="cp1.2" type=cited from="[2005] FCA 1218">application for injunctions for threatened infringement of patent</citphrase>
<citphrase id="cp1.3" type=cited from="[2005] FCA 1218">claim that patent is invalid</citphrase>
<citphrase id="cp1.4" type=cited from="[2005] FCA 1218">lack of novelty</citphrase>
<citphrase id="cp1.5" type=cited from="[2005] FCA 1218">obviousness</citphrase>
<citphrase id="cp1.6" type=cited from="[2005] FCA 1218">lack of fair basis</citphrase>
<citphrase id="cp1.7" type=cited from="[2005] FCA 1218">whether serious issue to be tried</citphrase>
<citphrase id="cp1.8" type=cited from="[2005] FCA 1218">whether applicant for injunctions would suffer irreparable harm for which damages would not be adequate compensation unless an injunction is granted</citphrase>
<citphrase id="cp1.9" type=cited from="[2005] FCA 1218">balance of convenience</citphrase>
<citphrase id="cp1.10" type=cited from="[2005] FCA 1218">proposed applications for listing of pharmaceutical products on the pharmaceutical benefits scheme</citphrase>
<citphrase id="cp1.11" type=cited from="[2005] FCA 1218">applications for injunctions refused</citphrase>
<citphrase id="cp2.0" type=cited from="[1986] HCA 58">injunctions</citphrase>
<citphrase id="cp2.1" type=cited from="[1986] HCA 58">public law</citphrase>
<citphrase id="cp2.2" type=cited from="[1986] HCA 58">restraint of enforcement of allegedly unconstitutional statute</citphrase>
<citphrase id="cp2.3" type=cited from="[1986] HCA 58">interlocutory injunction</citphrase>
<citphrase id="cp2.4" type=cited from="[1986] HCA 58">principles.</citphrase>
<citphrase id="cp4.0" type=citing from="[2010] FCA 38">trade practices</citphrase>
<citphrase id="cp4.1" type=citing from="[2010] FCA 38">misleading or deceptive conduct</citphrase>
<citphrase id="cp4.2" type=citing from="[2010] FCA 38">application for interim and other relief  practice and procedure</citphrase>
<citphrase id="cp4.3" type=citing from="[2010] FCA 38">interim injunction</citphrase>
<citphrase id="cp4.4" type=citing from="[2010] FCA 38">whether proof of irreparable injury is necessary in the circumstances  practice and procedure</citphrase>
<citphrase id="cp4.5" type=citing from="[2010] FCA 38">injunction sought at interlocutory stage</citphrase>
<citphrase id="cp4.6" type=citing from="[2010] FCA 38">order mandatory in character and final in form</citphrase>
<citphrase id="cp4.7" type=citing from="[2010] FCA 38">whether different standard applies  practice and procedure</citphrase>
<citphrase id="cp4.8" type=citing from="[2010] FCA 38">leave to file amended application and second further amended statement of claim  practice and procedure</citphrase>
<citphrase id="cp4.9" type=citing from="[2010] FCA 38">separate question</citphrase>
<citphrase id="cp4.10" type=citing from="[2010] FCA 38">whether premature to order a separate question to be determined  practice and procedure</citphrase>
<citphrase id="cp4.11" type=citing from="[2010] FCA 38">setting aside part of a subpoena</citphrase>
<citphrase id="cp4.12" type=citing from="[2010] FCA 38">whether documents sought are adjectivally relevant</citphrase>
</citphrases>
<citances>
<sentence id="cs0" from="[2010] FCA 38">There are a number of decisions of this Court where the formulation in Castlemaine Tooheys has been applied: see, for example, Aktiebolaget H&auml;ssle v Biochemie Australia Pty Ltd [2003] FCA 496 ; (2003) 57 IPR 1 at [29] ; Hexal Australia Pty Ltd v Roche Therapeutics Inc [2005] FCA 1218 ; (2005) 66 IPR 325 at [17] ; Pharmacia Italia SpA v Interpharma Pty Ltd [2005] FCA 1675 ; (2005) 67 IPR 397 at [9] - [10] ; Tu v Pakway Australia Pty Ltd (2006) 227 ALR 287 at [13]; Merck &amp; Co Inc v GenRx Pty Ltd [2006] FCA 1407 ; (2006) 70 IPR 286 at [16] ; CSL Ltd v GlaxoSmithKline Australia Pty Ltd [2006] FCA 1301 ; (2006) 70 IPR 128 at [58] - [59] ; Oxygen 8 Communications Australia Pty Ltd v Telstra Corporation Ltd [2009] FCA 426 at [20] . </sentence>
</citances>
<legistitles>
<title id="l0">THERAPEUTIC GOODS ACT 1989 </title>
<title id="l1">THERAPEUTIC GOODS ACT 1989 - SECT 21B General civil penalties relating to this Part</title>
<title id="l2">TRADE PRACTICES ACT 1974 </title>
<title id="l3">TRADE PRACTICES ACT 1974 No. 51, 1974 - SECT 52 Misleading or deceptive conduct.</title>
<title id="l4">FEDERAL COURT RULES 1979 </title>
</legistitles>
</case>